Safety and outcomes associated with tranexamic acid in patients with intracerebral hemorrhage


  • Tranexamic acid was not found to prevent intracerebral hemorrhage (ICH) growth but was safe, with no increase in thromboembolic complications.

Why this matters

    There are currently no acute therapies for ICH that have strong evidence to support their use, but ICH comprises 5% of deaths worldwide; proven treatments for ICH are needed.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.